Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH) Q4 2023 Earnings Conference Call February 22, 2024 5:00 PM ET

Company Participants

Seth Frank - Vice President of Investor Relations
Seth Blackley - Chief Executive Officer, Co-Founder and Board Member
John Johnson - Chief Financial Officer

Conference Call Participants

Andrea Alfonso - UBS
Jailendra Singh - Truist Securities
Jeff Garro - Stephens
Anna Kruszenski - Barclays
Ryan Daniels - William Blair
Kyle Aikman - JPMorgan
Jessica Tassan - Piper Sandler
Charles Rhyee - TD Cowen
Richard Close - Canaccord Genuity
Jenny Shen - BTIG
Tommy Schuyler - RBC Capital Markets
Jack Wallace - Guggenheim Securities

Operator

Welcome to the Evolent Earnings Conference Call for the Quarter and Year-Ended December 31, 2023. As a reminder, this conference call is being recorded. Host for the call today from Evolent are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer. The call will be archived and available later this evening and for next week via the webcast on the company's website in the section titled Investor Relations.

I'll now hand the call over to Seth Frank, Evolent's Vice President of Investor Relations.

Seth Frank

Thank you, and good evening. This conference call will contain forward-looking statements under the U.S. Federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our fourth quarter press release issued earlier today.

Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in